Moderna Inc., US60770K1079

Moderna stock gains 5.16 percent after the close

Published on 09/22/2026 at 22:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Moderna stock had gained 5.16 percent in U.S. trading. The shares traded between USD 168.30 and USD 187.20, while detailed cancer data is scheduled for October 24, 2026.

Isometrische 3D-Grafik zeigt Pharma-Wertschöpfungskette von Labor bis Krankenhaus
Moderna Inc. (US60770K1034) illustriert die isometrische Wertschöpfungskette der Biotech-Branche von Forschung bis zur finalen Auslieferung, Illustration mit AI erstellt.

Moderna stock closed at USD 181.94 on the Nasdaq on September 22, 2026, up 5.16 percent from the prior close. The session range was USD 168.30 to USD 187.20, placing the close USD 5.26 below the session high.

September 22, 2026 in numbers

Moderna Inc. (ISIN US60770K1079, Nasdaq: MRNA) finished the session at USD 181.94 after trading as low as USD 168.30 and as high as USD 187.20. The shares outperformed the pharmaceuticals and medical research sector, which rose 0.57 percent, according to TradingKey. The S&P 500 gained 1.49 percent to 7,764.70, providing a broader positive market comparison.

Moderna cancer data on October 24, 2026

Moderna has three abstracts on intismeran autogene scheduled for the ESMO Congress in Madrid from October 23 to October 27, 2026. The Phase 3 melanoma study is scheduled for a Presidential Symposium on October 24 at 10:30 a.m. ET, and the company webcast is scheduled for 1:00 p.m. ET, according to BioSpace.

Disclaimer...

en | US60770K1079 | MODERNA INC. | boerse | 70159696 | bgmi